PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-21

Date Title Company
21-Apr-2026 UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science UCB
21-Apr-2026 2025 Impact Report Shows Soluna Continuing to Expand Reach and Impact Kooth
21-Apr-2026 Peer-Reviewed Article Shows Superior Hemolysis Profile in Realheart® TAH Compared to Market-Leading Device Scandinavian Real Heart AB
21-Apr-2026 CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Businesswire
21-Apr-2026 First-of-its-kind study highlights the critical role of essential phospholipids in improving Fatty Liver Disease. Opella
21-Apr-2026 Cochrane review shows the drugs don’t work – what is the solution for Alzheimer’s? Cochrane
21-Apr-2026 Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy Asahi Kasei
21-Apr-2026 Last patient has completed AlzeCure's Phase Ib clinical study with NeuroRestore ACD856 AlzeCure
21-Apr-2026 KEDRION ACCELERATES GROWTH BUILT ON FOUNDATIONS OF TRANSFORMATION AND GLOBAL EXPANSION KEDRION
21-Apr-2026 Mental health performance target needed to address "appalling treatment gap" for children and young people The NHS Alliance
21-Apr-2026 Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD Astrazeneca
21-Apr-2026 Qlucore Launches AI-based test for Bladder Cancer Qlucore
21-Apr-2026 QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics QuidelOrtho Corporation
21-Apr-2026 Intelligent automation for laboratory workflows Beckhoff
21-Apr-2026 Model N Manages $1.3 Trillion in Gross Revenue for Life Sciences Customers Model N
21-Apr-2026 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026 Businesswire
21-Apr-2026 genedrive plc (“genedrive” or the “Company”) Consultation to inform NHS England commercial strategy for rapid MT-RNR1 testing genedrive plc
21-Apr-2026 Medivir participates in the partner and investor conferences Nordic Health Summit in Japan/Korea and BIO KOREA 2026 Medivir
21-Apr-2026 Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit ™, as it moves to commercialization Xeltis
21-Apr-2026 FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Businesswire